Want to join the conversation?
$SIAL's research and development expenses for 3Q15 rose slightly by $1MM from 3Q14, as result of inclusion of R&D resulting from purchase of Cell Marque and higher spending on various R&D programs. R&D expenses relate primarily to efforts to add new manufactured products, create and develop new technologies and enhance manufacturing processes.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th